WICK Sinex avera dosing spray, 15 ml

Instructions for use for WICK Sinex avera dosing spray, 15 ml

Detailed instructions for WICK Sinex avera dosing spray, 15 ml

Field of use

Wick Sinex avera 0.5 mg/ml (pack size: 15 ml) has a rapid and long -lasting effect on acute and allergic runny nose. The nasal mucosa swells and the secretion drain is relieved so that you can breathe freely for up to 8 hours. Wick Sinex Avera 0.5 mg/ml (pack size: 15 ml) not only has a quick and long -lasting effect, but is also beneficial for the nose due to the moisture regulators aloe vera and sorbitol.

Mode of action

The active ingredient oxymetazoline hydrochloride contained in Wick Sinex avera 0.5 mg/ml (pack size: 15 ml) has vascular properties. The clogged nose is freed from the mucus and breathing is easier. A small proportion of essential oils also ensures a gentle feeling of freshness. The nasal mucosa is retained from drying out by the Sorbitol and Aleo Vera moisture regulator.

Active ingredients / ingredients / ingredients

Wick Sinex avera 0.5 mg/ml (pack size: 15 ml) contains:

• 0.5 mg/ml oxymetazolin hydrochloride (corresponds to 0.439 mg oxymetazoline)
• Cineol

Other components of Wick Sinex Avera 0.5 mg/ml (pack size: 15 ml):

Acesulfam potassium; Aloes extractum; Benzalkonium chloride; Chlorhexidine Digluconat; Citronic acid dinatrium defeat; Levomenthol; Sodium citrate 2H2o; Sodium hydroxide; Sorbit; Tyloxapol; Water, cleaned

Contradictions

In the case of known hypersensitivity to one of the ingredients, dry inflammation of the nasal slime (rhinitis sicca), children under 6 years, pregnancy and breastfeeding should not be used.
Special caution and intake only under medical control at: chronic runny nose, green star (glaucoma), severe cardiovascular diseases (e.g. in the case of diseases of cardiac cards, high blood pressure), metabolic disorders (e.g. overactive thyroid, diabetes), pheochromocytoma, prostate hyperplasia, porphyria , Patients who are treated with MAO inhibitors and other potentially blood pressure-enhancing medicines.

dosage

Application recommendation of Wick Sinex Avera 0.5 mg/ml (pack size: 15 ml): Adults and children from 6 years spray Wick Sinex avera 0.5 mg/ml (pack size: 15 ml) 1x every 7-10 hours in each nasal side every 7-10 hours.

The application of Wick Sinex Avera 0.5 mg/ml (pack size: 15 ml) should be limited to a maximum of 3 applications per day. The product must not be used for more than 5-7 days without medical advice. A new application should only take place after a break of several days. The duration of use in children is generally determined by a doctor.

Be sure to avoid long -term application and overdose, especially in children.

Hints

Wick Sinex avera nasal spray 0.5 mg/ml solution
Active ingredient: oxymetazolin hydrochloride 0.5 mg/ml. Supplement: 1 spray (50 µl) contains approx. 25 micrograms oxymetazolin hydrochloride. Otherwise. Exist.: Sorbitol, sodium citrate (Ph.Eur.)*, Polysorbate 80, benzyl alcohol, water-free citric acid*, benzalkonium chloride solution, acesulfam potassium, levomenthol, cineol, sodium defeat (Ph. EUR.), Aloet dry extract, L-carvon, cleaned water. * for pH setting. Vermit: Symptomatic Treating from Nasal mucus swelling. From age 6. Against.: Hypersensitivity of the active ingredient, levomenthol, benzyl alcohol, cineol or a d. otherwise. or Herzasthma. Warnhinw.: Cont. Benzalkonium chloride, benzyl alcohol, levomenthol, cineol. Next: Occasionally: sneezing, dryness and stimulus symptoms in the nose, mouth and throat. Rarely: anxiety, sedation, irritability, sleeping storms. Tachycardia, palpitations, increased blood pressure. Reactive hyperemia, headache, nausea, rash and visual courses. Frequency unknown: hypersensitivity reactions (including shortness of breath) and allergic reactions against benzyl alcohol. A crossing of the recommended use duration can be taken to take effect and/od. lead to a rebound congregation effect. Tax status: subject to pharmacy. Pharmaceutical entrepreneur: Wick Pharma, branch of the Procter & Gamble GmbH, D-65823 Schwalbach As of April 2021.